Friday, July 10, 2020 11:14:00 AM
Being a committed long, here are a few items I see which may help:
1. The quarterly earnings review came out this week. While it didn't indicate a groundbreaking new revenue stream, it clearly demonstrated that the redomiciling definitely made good sense. Now behind us, I await Avita finding a more stable footing in the stock market environment shattered by Covid-19 and various other issues affected by politics. For me, personally, most conspicuous is that we added seven (7) additional burn centers over the course of the quarter. We are now under contract with more than half of the burn centers in America. Undeniably we are now past the 50% point on the road to becoming heralded as the "standard of care."
2. Despite horrendous impact on every aspect of business represented by public trading status, we held our own rather magnificently in my opinion. Initiatives continue to move forward where possible with numerous earlier ones being pursued via clinical launches both new and continuing. I sense an air of calm exhibited by DR. Perry for which I am grateful. "Steady as she goes!" is a fine way to bring home the ship.
3. Today we're seeing the shoreline splashing a bit. So it raises the question:
How much should we be--or are--threatened?
Let me suggest readers consider doing what I do:
Set a price point that would have you/me buying more shares. Obviously it has to be a smart price well beneath the prevailing cost basis. More than that, however, is to determine a fire-sale price point that couldn't damage your longer range plan.
Prior to the reverse split, I'd set (in my mind) a $5/share threshold. This translates into an identical price point today of $25/share.
There's a caveat, however: Today we are a nation faced with an out of control pandemic. For me that spells "All bets are off" at least for the moment. What this means is that while many would support my $25 thesis, I'm not so sure that the pandemic doesn't cast a still more darkening cloud over things.
Looking at the momentum factor today bringing us more than $2 lower, I believe I will nibble at $25 but will do so more cautiously than earlier anticipated.
More later as the picture develops and we have greater clarity.
Roundup:
There are some who will put down management, company technology, and whatever soothes the savage spirit within. And I believe the majority here recognize those individuals for what they are, or aren't, as the case may be.
For the record, I'm older than most here. I could not be a happier man with the exception of not being free to be with friends in favorite haunts. Too, there's the constant threat of the terrible illness responsible for so many deaths and internal disfigurements to say nothing of the permanent losses to those left behind.
This is what I'm doing:
I am looking past today, past next month, next year. I'm making deliberate moves to remove myself from a time-based continuum. This is not a time for me to count on anything but hanging onto those things most dear to me---my wife, my friends, my life as defined by my estate and the freedom to live well. Waking up and kissing my wife is the perfect blessing for my day. Knowing I have the freedom to order food online without subjecting myself to needless health risks is of paramount importance.
In short, I've been resigning myself this week to accepting that I cannot change the course of the Corona virus. Nor can I save lives destined to become the next wave of victims.
But there's one thing I believe I can do:
I can ask folks to let go of immediate gratification. We buy, sell and trade stocks for profit, fun and a sense of identity. But there are time-based circumstances very much a part of the investing cycle, and undeniably so, at that.
Thus it is that while it'd be wonderful to read that one of my main portfolio picks issues groundbreaking news regarding a fantastic development, I'm not willing to allow myself such foolish fantasies. For now I'm looking at what I have good reason to expect over the course of the next year to two years. Anything really exciting along the way between then and now? A little of excitement never hurts, right?
The hardest part of this for me is accepting there's a new paradigm in play and I must accept it. To do less is to willfully damage myself in countless ways.
So then, I'm asking others to think about what their market affiliation is all about and then consider revising landmarks so that acceptance becomes easier.
Thank you.
Recent RCEL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 12:48:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 11:36:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:39:30 PM
- AVITA Medical Achieves Milestone with First Case Using RECELL GO • GlobeNewswire Inc. • 06/05/2024 08:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:34:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:28:05 PM
- AVITA Medical Announces FDA Approval of RECELL GO • GlobeNewswire Inc. • 05/30/2024 01:15:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 05/16/2024 10:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:02:24 PM
- AVITA Medical Reports First Quarter Financial Results • GlobeNewswire Inc. • 05/13/2024 08:01:00 PM
- AVITA Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/15/2024 09:05:00 PM
- AVITA Medical Updates Expected First Quarter 2024 Revenue • GlobeNewswire Inc. • 04/10/2024 09:11:25 PM
- AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement • GlobeNewswire Inc. • 02/29/2024 09:02:00 PM
- AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 02/23/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:02:06 PM
- AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:12 PM
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific • GlobeNewswire Inc. • 01/10/2024 09:01:00 PM
- AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update • GlobeNewswire Inc. • 01/10/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:51:10 PM
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 12/04/2023 02:00:00 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM